Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state

Am J Hematol. 2017 Sep;92(9):E549-E552. doi: 10.1002/ajh.24804. Epub 2017 Jul 19.

Authors

Affiliations

¹ Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
² Division of Oncology, Washington University School of Medicine, Bone Marrow Transplantation and Leukemia, St. Louis, Missouri.
³ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
⁴ Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.

No abstract available

Publication types

Letter
Review

MeSH terms

Adult
Aged
Allografts
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / pathology*
Cladribine / administration & dosage
Combined Modality Therapy
Cytarabine / administration & dosage
Etoposide / administration & dosage
Female
Filgrastim / administration & dosage
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / therapeutic use
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Mitoxantrone / administration & dosage
Myelodysplastic Syndromes / drug therapy
Myelodysplastic Syndromes / pathology
Myelodysplastic Syndromes / therapy*
Transplantation Conditioning
Treatment Outcome
Young Adult

Substances

Immunosuppressive Agents
Cytarabine
Cladribine
Etoposide
Mitoxantrone
Filgrastim

Grants and funding